Editorial Board ::: Current Biotechnology

ISSN: 2211-551X (Online)
ISSN: 2211-5501 (Print)


Volume 5, 4 Issues, 2016


Download PDF Flyer




Current Biotechnology

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Pabulo Henrique Rampelotto
Center of Biotechnology and PPGBCM
Federal University of Rio Grande do Sul
Porto Alegre, RS
Brazil


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Editorial Board

Editor-in-Chief:

Pabulo Henrique Rampelotto (Biography
Pabulo Henrique Rampelotto

Pabulo Henrique Rampelotto is a molecular biologist currently developing his research at the Federal University of Rio Grande do Sul (Brazil). He is Editor-in-Chief of Current Biotechnology and the book series Grand Challenges in Biology and Biotechnology (Springer). He also serves as Associate Editor, Guest Editor and member of the Editorial Board of several scientific journals in the field of Life Sciences and Biotechnology. In his editorial books and special issues, some of the most distinguished team leaders in the field have published their work, ideas and findings, including Nobel Laureates and several of the highly cited scientists according to the ISI Institute.

For more information, please visit: https://www.amazon.com/Pabulo-Henrique-Rampelotto/e/B004I2L63G, https://lifeboat.com/ex/bios.pabulo.henrique.rampelotto

)

Center of Biotechnology and PPGBCM
Federal University of Rio Grande do Sul
Porto Alegre, RS
Brazil



Associate Editor(s):

Michael W. W. Adams
Distinguished Professor
University of Georgia
Athens, GA
USA

Francis J. Castellino
Dean Emeritus
College of Science, University of Notre Dame
Notre Dame, IN
USA

Jean-Marie Frère (Biography
Jean-Marie Frère

Jean-Marie Frère obtained a PhD from the University of Montréal (1969) and, after a one-year post-doctoral position at MIT (Cambridge, Mass, USA), an "Agrégation de l'Enseignement supérieur" from the University of Liège in 1976.

From the beginning, he has worked in the field of enzymology and, after 1970, mainly devoted his attention to the mode of action of beta-lactams and to the enzymes involved in the sensitivity or resistance of bateria to this family of antibiotics, i.e. DD-peptidases (or Penicillin binding proteins) and beta-lactamases.

)

Emeritus Professor
University of Liège
Liège
Belgium

Yasuhisa Asano
Director
Biotechnology Research Center, Toyama Prefectural University
Toyama
Japan

Thomas M.S. Chang
Director
Artificial Cells & Organs Research Centre / Emeritus Professor, Faculty of Medicine, McGill University
Quebec
Canada

Ben Lugtenberg (Biography
Ben Lugtenberg

Dr Ben J J Lugtenberg graduated in Chemistry from Utrecht University and received his PhD in 1971. His studies included (i) mechanisms of action of antibiotics, (ii) structure and biogenesis of bacterial outer membranes, (iii) nodulation and nitrogen fixation by Rhizobium, (iv) plant growth promotion and biocontrol of plant diseases, and (v) bacterial and fungal endophytes. According to the Web of Science he has 238 primary publications, was cited by others over 15,000 times and has a Hirsch index of 70.

)

Emeritus Professor
Leiden University
Leiden
Netherlands

Peter L. Bergquist
Emeritus Professor
Macquarie University
Sydney
Australia

Paul C. Engel (Biography
Paul C. Engel

Paul Engel graduated in Biochemistry at Oxford (1965). A D. Phil. on enzyme kinetics (Oxford, 1968) followed by 2 years studying flavoproteins with Vincent Massey (University of Michigan). On staff of University of Sheffield 1970-1994. Founding Director of Sheffield’s Krebs Institute. Two-year secondment to manage UK Biotechnology Directorate’s ‘Protein Engineering Club’ (late 1980s). From 1994 Professor of Biochemistry at University College Dublin. Research on various enzymes, mainly dehydrogenases, exploring mechanism, genetic errors, protein engineering, biocatalysis etc. Author of Enzyme Kinetics, the Steady-state Approach (1977, 1981) and Pain-free Biochemistry (2009).

)

Emeritus Professor
University College Dublin
Dublin
Ireland

Charles E. Wyman (Biography
Charles E. Wyman

Dr. Charles Wyman leads advancement of cellulosic biomass conversion to sugars and other precursors for biological or catalytic conversion to fuels and chemicals. He is Ford Motor Company Chair in Environmental Engineering and Distinguished Professor in Chemical and Environmental Engineering at the University of California, Riverside. Prior positions include Queneau Distinguished Professor at Dartmouth College and Director of the Biotechnology Center as well as previous positions at the National Renewable Energy Laboratory. Dr. Wyman is founder of Vertimass to commercialize simple ethanol conversion to fungible fuels and was cofounder of Mascoma Corporation. He is a AIChE and AAAS Fellow.

)

Distinguished Professor
University of California
California, CA
USA


Editorial Board Members:

Ralf Anken
German Aerospace Center
Cologne
Germany

Dominique Bonnet
Cancer Research UK
London
UK

Wilfred Chen (Biography
Wilfred Chen

Professor Wilfred Chen joined the University of Delaware in January 1, 2011 as the Gore Professor of Chemical Engineering. He obtained his B.S. degree from UCLA in 1988 and his Ph.D. from Caltech in 1993, both in Chemical Engineering. After one-year postdoc in Switzerland, he joined UC Riverside in 1994. He was Professor of Chemical and Environmental Engineering and the holder of Presidential Chair until 2010. His research interests are in Synthetic Biology and Protein Engineering. Prof. Chen has published more than 220 journal papers and delivered over 70 invited lectures. He serves on the editorial board for seven scientific publications including Applied and Environmental Microbiology and Biotechnology and Bioengineering. He is a fellow of the American Association for the Advancement of Science (AAAS) and the American Institute for Medical and Biological Engineering (AIMBE).

Prof. Chen has also received several awards, including NSF Career Award, AIChE Food, Pharmaceutical, and Bioengineering Division 15c Plenary Lecture, Biotechnology Progress Award for Excellence in Biological Engineering Publication, and Daniel I.C. Wang Award for Excellence in Biochemical Engineering.

)

University of Delaware
Newark, DE
USA

Dongsheng Duan
University of Missouri
Columbia, MO
USA

Michael Hust (Biography
Michael Hust

Michael Hust studied biology at the Carl von Ossietzky Universität in Oldenburg, Germany, from 1993-1999. He received his PhD from the Leibniz Universität in Hannover, Germany, in 2002. Since end of 2002 he is working as group leader at the Technische Universität Braunschweig, Germany. In 2011, he finished his professorial dissertation (Habilitation) and was appointed as Privatdozent (PD). In 2014 he was appointed as professor for biotechnology.

He published more than 100 articles (including book chapters and reviews) on antibody engineering and phage display. He is working on the development of human and human-like antibodies for proteome research, diagnostics and therapy with a focus on pathogens and toxins. Another field of interest is the identification of biomarkers of pathogens using phage display. He co-founded two biotech companies, the mAb-Factory GmbH in 2007 and the YUMAB GmbH (www.yumab.com) in 2012.

)

Technische Universität Carolo-Wilhelmina zu Braunschweig
Braunschweig
Germany

Alexander M.Seifalian (Biography
Alexander M.Seifalian

Alexander M. Seifalian (AMS) is director of Nanotechnology & Regenerative Medicine Commercialisation at the London BioScience Innovation Centre and Professor of Nanotechnology and Regenerative Medicine. He is Fellow of the Institute of Nanotechnology (FIoN) and Society of Biology (FSB), and has published over 650 peer-reviewed articles, two books and 12 international patents. AMS has a significant track record with regard to generating impact through the translation of technology from the laboratory directly to the clinic and has demonstrated that nanocomposite materials and stem cells are core to the next generation of surgical implants with highly successful outcomes in a number of pioneering projects. This led to the development of the world’s first synthetic trachea, nasal and ear reconstruction, lacrimal duct conduit, and small diameter bypass grafts for coronary artery and vascular replacement, which has entered clinical trials, all of which have been used as first-in-man.

)

University College London
London
UK

Argyrios Margaritis
University of Western Ontario
Ontario
Canada

Ryuichi Morishita (Biography
Ryuichi Morishita

Ryuichi Morishita, M.D., Ph.D., graduated Osaka University Medical School in 1987, and received Ph. D. from Osaka University in 1991. After postdoctoral Fellow at Stanford University School of Medicine, he served as an Assistant Professor, Department of Geriatric Medicine, Osaka University Medical School from 1994 to 1998. Then, from 1998 to 2003, he was Associate Professor, Division of Gene Therapy Science, Osaka University Medical School. Then, he became Professor & Chairman of Division of Clinical Gene Therapy, Graduate School of Medicine, Osaka University Medical School from 2003.

)

Osaka University
Osaka
Japan

Kun Ping Lu (Biography
Kun Ping Lu

Kun Ping Lu, MD, PhD, is a Professor of Medicine at Harvard Medical School and the Chief of the Division of Translational Therapeutics at Beth Israel Deaconess Medical Center. He discovers a unique phosphorylation-specific proline isomerase, Pin1 that helps protect against Alzheimer’s disease and whose aberrant activation helps promote the development of cancer. Based on these discoveries, his laboratory is working to develop an antibody therapy for the early diagnosis and treatment of Alzheimer’s and traumatic brain injury, and Pin1 chemical inhibitors to overcome drug resistance in cancer treatments.

)

Harvard Medical School
Boston, MA
USA

Daniel Rittschof
Duke University Marine Laboratory
Beaufort, NC
USA

Dmitry Shayakhmetov
University of Washington
Seattle, WA
USA

Tore Straume
NASA Ames Research Center
Moffett Field, CA
USA

Nicholas J. Turner
Manchester Institute of Biotechnology, University of Manchester
Manchester
UK

Shang-Tian Yang
The Ohio State University
Columbus, OH
USA

Willem JH van Berkel
Wageningen University
Wageningen
The Netherlands

Rainer Borriss
Humboldt University
Berlin
Germany

Stephen Dalton
University of Georgia
Athens, GA
USA

Alessandro Giuliani (Biography
Alessandro Giuliani

Alessandro Giuliani took his Laurea in Biological Sciences at Universita' di Roma "La Sapienza" score 110/110 cum laude (Anno Accademico 81/82) with a specialization in Statistics.. He serves as Senior Scientist at Environment and Health Dept. Istituto Superiore di Sanità, Roma,Italy (1997- ). He is Professor (on contract basis) at Pontifical Urbaniana University, Rome. Dr. Alessandro Giuliani is involved since more than thirty years in the generation and testing of soft physical and statistical models for life sciences. He puts a a special emphasis on the elucidation of mesoscopic complex systems like protein sequence/structure prediction, complex network approaches, QSAR, Systems Biology. He contributed (together with Prof. Zbilut and Prof. Webber) to the development of Recurrence Quantification Analysis (RQA) data analysis technique. He is the author of 278 publications on peer-review journals with an H-index = 38.

)

Istituto Superiore di Sanitá
Rome
Italy

Vinod Labhasetwar
Cleveland Clinic Lerner College of Medicine
Cleveland, OH
USA

Datta Madamwar
Sardar Patel University
Vallabh Vidyanagar
India

Nicolas Mermod
Director of Institute of Biotechnology
Lausanne
Switzerland

Poonam Singh Nigam (Biography
Poonam Singh Nigam

Dr Poonam Singh (Nigam), PhD in Industrial Microbiology (1985), Postdoctoral Research Fellow Germany (1985-1988), joined Ulster University, UK as full time staff in 1990. Qualified as Chartered Biologist (1992), received Post-graduate qualification in University Teaching, UK (1998), the status of Fellow and Senior Fellow - The Higher Education Academy, UK in 2007 and 2014, respectively; Fellow of Royal society of Biology, London UK, Fellow - Centre of Higher Education Research & Practice, UK 2014, Fellow - International Forum on Industrial Bioprocesses, France 2014, Fellow - The Biotechnology Research Society India (2013). Google Scholar http://scholar.google.co.uk/citations?user=-Pkpe_cAAAAJ&hl=en

)

University of Ulster
Coleraine
UK

Guy M. Poppy
University of Southampton
Hampshire
UK

Badal C. Saha
National Center for Agricultural Utilization Research
Peoria, IL
USA

Ashok Shetty
Duke University Medical Centre
Durham, NC
USA

Jeffrey P. Sutton
President, CEO and Institute Director, National Space Biomedical Research Institute
Houston, TX
USA

Jeremy S. Webb
University of Southampton
Southampton
UK

Su-Chun Zhang
University of Wisconsin
Madison, WI
USA

Ben Berkhout
University of Amsterdam
Amsterdam
The Netherlands

Bruce A. Bunnell
Tulane University Health Sciences Center
Covington, LA
USA

Nikolay V. Dokholyan
University of North Carolina
Chapel Hill, NC
USA

Jose M. Guisan
Instituto de Catalisis CSIC
Madrid
Spain

Yuehe Lin (Biography
Yuehe Lin

Dr. Yuehe Lin is a professor in School of Mechanical and Materials Engineering, Washington State University (WSU). He also holds a joint appointment at Pacific Northwest National Laboratory (PNNL), conducts research in nanotechnology, particularly development of small-scale devices, materials and analytical systems for biomedical diagnosis, drug delivery and energy and environmental applications. He has ~400 publications with a total citation about 33,000 and h-index 95. He was listed in Thomson Reuters’s highly-cited researchers in 2014, 2015 and 2016. Dr. Lin has over 10 patents. Half of the patents have been licensed to industrial partners for commercialization. He is a fellow of AAAS, Royal Society of Chemistry, and American Institute of Medical and Biological Engineering.

)

Washington State University
Pullman, WA
USA

Shawn Mansfield
University of British Columbia
Vancouver
Canada

Damiano Gustavo Mita (Biography
Damiano Gustavo Mita

Graduated in Physics on December 1969, started his scientific career on 1970 as Researcher of CNR becoming successively Director of Research. Since 1991 Prof. Mita has become full professor of Biophysics at the Second University of Naples. His main research activity is focused on the application of the technology of immobilized enzymes in agro-food and pharmaceutical industry, and in the field of ecotoxicology, particularly on the effects of endocrine disruptors in living organisms. Prof. Mita authored 130 papers, several chapters and some patents.

Actually Prof. Mita is Director of the National Laboratory on Endocrine Disruptors of the Interuniversity Consortium INBB .

)

Institute of Genetics and Biophysics - CNR via Pietro Castellino
Naples
Italy

Girdhar K. Pandey (Biography
Girdhar K. Pandey

Prof. Pandey received Ph.D. from Jawaharlal Nehru University (JNU), India and pursed his post-doctoral research work at the Department of Plant and Microbial Biology, University of California at Berkeley. Currently, he is working as Professor in the Department of Plant Molecular Biology, Delhi University South Campus. His group’s research interest is to understand the detail mechanistic interplay of signal transduction networks in plants under mineral nutrient deficiency and abiotic stresses. He has published more than 60 scientific publications, edited 7 books/volumes and also has 2 US patents.

Visit his lab web-page for further information about research work: http://www.dpmb.ac.in/index.php?page=girdhar-pandey; https://sites.google.com/site/gkplab/home

)

University of Delhi South Campus
New Delhi
India

Arthur J. Ragauskas (Biography
Arthur J. Ragauskas

Arthur Ragauskas held the first Fulbright Chair in Alternative Energy and is a Fellow of American Association for the Advancement of Science, the International Academy of Wood Science and TAPPI. In 2014, he assumed a Governor’s Chair for Biorefining based in University of Tennessee’s Department of Chemical and Biomolecular Engineering, with a complementary appointment in the UT Institute of Agriculture’s Department of Forestry, Wildlife, and Fisheries and serves in the US Energy and Environmental Sciences Directorate, Biosciences Division, at ORNL. His research program is directed at understanding and exploiting innovative sustainable bioresources for biofuels, and bio-based materials and chemicals.

)

University of Tennessee
Knoxville, TN
USA

Peer Schenk
The University of Queensland
Brisbane
Australia

Alison Smith
University of Cambridge
Cambridge
UK

Tomohiro Tamura
National Institute of Advanced Industrial Science and Technology
Sapporo
Japan

Peter X. Ma
University of Michigan
Ann Arbor, MI
USA

Ruiwen Zhang (Biography
Ruiwen Zhang

Dr. Zhang has extensive expertise and experiences in translational biomedical research, particularly translational medicine, cancer therapy and prevention, pharmacogenomics and therapeutics. He has published more than 210 papers, 2 books, more than 50 invited reviews/book chapters, and more than 180 meeting abstracts. Dr. Zhang has made more than 200 invited presentations. He is a certified toxicologist by the American Board of Toxicology (D.A.B.T.). He is also an editor-in-chief, associate-editor-in-chief, associate editor, or editorial board member of 25 scientific journals. Dr. Zhang has been elected as a Fellow of American Association for the Advancement of Science (AAAS) since 2009.

)

Texas Tech University Health Sciences Center
Amarillo, TX
USA


Editorial Board Members: (Biotechnology Industry)

Malaz Abutarif
Director
Bristol-Myers Squibb
Princeton, NJ
USA

David Boulton
Executive Director, AstraZeneca
Gaithersburg, MD
USA

Stevan W. Djuric
Senior Director, AbbVie
Chicago, IL
USA

William Kennedy
Senior Medical Director
Genentech
South San Francisco, CA
USA

Jesper Lau
Vice President
Novo Nordisk
Copenhagen
Denmark

Michael Linden
Vice President, Gene Therapy, Pfizer
London
UK

T. Shantha Raju (Biography
T. Shantha Raju

Dr. Raju obtained a doctorate (Ph.D.) in Chemistry from the University of Mysore, Mysore, INDIA. Dr. Raju also holds a Masters in Chemistry from the University of Mysore. Currently Dr. Raju is a Senior Director and Head of Global Bioassay & Quality at Medimmune. He has published more than 40 scientific publications including several book chapters and is named inventor of several issued U.S and worldwide patents. Dr. Raju is currently serving as the Editorial Board member of several journals.

)

Scientific Director, Janssen, Pharmaceutical Companies of Johnson and Johnson
Springhouse, PA
USA

Rob Scott
Vice President and Head
Amgen
Los Angeles, CA
USA

Michael Teufel
Director
Bayer HealthCare
New York, NY
USA

Dennis M. Zaller
Executive Director, Celgene
Boston, MA
USA

Khursheed Anwer
President and Chief Scientific Officer, EGEN
Huntsville, AL
USA

Seng H. Cheng
Vice President
Genzyme Corporation
Framingham, MA
USA

Nancy B. Griffith
Vice President, Biogen Idec
Boston, MA
USA

Manfred Kircher
Chairman of the Advisory Board, Cluster Industrielle Biotechnologie - CLIB2021
Düsseldorf
Germany

Tarek Leil
Director, Bristol-Myers Squibb
Princeton, NJ
USA

Faisal Mehmud
Vice President
Novartis
East Hanover, NJ
USA

John J. Renger (Biography
John J. Renger

John leads the clinical research group within Purdue Pharma, Stamford, CT. Prior to joining Purdue, Dr. Renger spent 15 years with Merck where he was a key innovator for Belsomra, a first-in-class dual orexin receptor antagonist for primary insomnia. John was a Merck-MIT Fellow at the Massachusetts Institute of Technology, where his work focused on understanding the genetic, developmental and physiological basis of memory. Before MIT, Dr. Renger worked at the Institute for Chemical and Physical Research, RIKEN, Japan studying the genetic basis of plasticity in the visual system. Dr. Renger earned his B.S. and Ph.D. degrees in biology from the University of Iowa.

)

Associate Vice President
Merck
West Point, PA
USA

Bernardo Silva
Executive President
Brazilian Industrial Biotechnology Association (ABBI)
São Paulo
Brazil

Michael Wagner
Director and Head
Sanofi
Frankfurt
Germany

Alex Berlin
R&D Director Biotechnology Research, Novozymes
Davis, CA
USA

Neil J. Clarke
Director & Head of Molecular Profiling, GlaxoSmithKline
Stevenage
UK

Rafiq Hasan
Vice President and Global Head
Bayer HealthCare
Newbury
UK

Alexandra Kropotova
Vice President and Head
Sanofi
Bridgewater, NJ
USA

Stacy R. Lindborg
Vice President, Biostatistics, Biogen Idec
Cambridge, MD
USA

Jose Ricardo Perez
Senior Medical Director
Novartis
East Hanover, NJ
USA

Alison Schecter
Vice President, Johnson & Johnson Innovation Center
Boston, MA
USA

Paul-Peter Tak (Biography
Paul-Peter Tak

Paul-Peter Tak received his medical degree cum laude from the Free University in Amsterdam and was trained as an internist, rheumatologist and immunologist at Leiden University Medical Center, where he also received his PhD. He served as Professor of Medicine and Chair of the Department of Clinical Immunology and Rheumatology at the Academic Medical Centre/University of Amsterdam (AMC) for 12 years. He is currently Chief Immunology Officer and Senior Vice President R&D Pipeline at GSK. He has published extensively in peer-reviewed scientific journals and is a Fellow of the Academy of Medical Sciences.

)

Senior Vice President, GlaxoSmithKline
Stevenage
UK

Scott Wasserman (Biography
Scott Wasserman

Dr. Wasserman received his M.D., Magna Cum Laude from Harvard Medical School and his B.S., Magna Cum Laude from Haverford College. He completed his postgraduate training in Internal Medicine and Cardiovascular Medicine at Stanford University.

Currently, Dr. Wasserman is the Vice President, Head of the Cardiovascular and Metabolic Therapeutic Area and Head of the Development Design Center at Amgen. He is responsible for Amgen’s cardiovascular and metabolic strategy through the development and registration of novel cardiovascular and metabolic therapeutics, evaluating and in-licensing external assets, and optimizing and innovating the design of clinical development programs and studies across Amgen.

)

Vice President
Amgen
Thousand Oaks, CA
USA


Advertisement

Related Journals




Related eBooks


Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science